Simple jQuery Dropdowns

Browsing by Author Justin A. Green

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
1-Nov-2017A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malariaMark M. Fukuda; Srivicha Krudsood; Khadeeja Mohamed; Justin A. Green; Sukhuma Warrasak; Harald Noedl; Ataya Euswas; Mali Ittiverakul; Nillawan Buathong; Sabaithip Sriwichai; R. Scott Miller; Colin Ohrt; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; GlaxoSmithKline plc.; Walter Reed Army Institute of Research; Medizinische Universitat Wien; Bangkok Hospital Medical Center; Bill and Melinda Gates Foundation; Consortium for Health Action
1-Jan-2014Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): A multicentre, double-blind, randomised, phase 2b dose-selection studyAlejandro Llanos-Cuentas; Marcus V. Lacerda; Ronnatrai Rueangweerayut; Srivicha Krudsood; Sandeep K. Gupta; Sanjay K. Kochar; Preetam Arthur; Nuttagarn Chuenchom; Jörg J. Möhrle; Stephan Duparc; Cletus Ugwuegbulam; Jörg Peter Kleim; Nick Carter; Justin A. Green; Lynda Kellam; Universidad Peruana Cayetano Heredia; Fundacao de Medicina Tropical do Amazonas; Mae Sot General Hospital; Mahidol University; MV Hospital and Research Centre; Sardar Patel Medical College; Sri Ramachandra Medical College & Research Institute (Deemed University); Medicines for Malaria Venture; GlaxoSmithKline plc.
18-Feb-2016Tafenoquine treatment of Plasmodium vivax malaria: Suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trialPamela L. St Jean; Zhengyu Xue; Nick Carter; Gavin C.K.W. Koh; Stephan Duparc; Maxine Taylor; Claire Beaumont; Alejandro Llanos-Cuentas; Ronnatrai Rueangweerayut; Srivicha Krudsood; Justin A. Green; Justin P. Rubio; PAREXEL International; GlaxoSmithKline plc.; Medicines for Malaria Venture; Universidad Peruana Cayetano Heredia; Mae Sot General Hospital; Mahidol University; University of Melbourne